Table 1 Demographic characteristics, underlying diseases, clinical and laboratory findings, and outcomes
| Â | Group | p | |
|---|---|---|---|
Case (n = 30) | Control (n = 30) | ||
Age (year), mean (SD) | 57.53 (18.27) | 61 (15.90) | 0.436 |
Sex, n (%) | |||
 Female | 15 (50.00%) | 15 (50.00%) | > 0.9 |
 Male | 15 (50.00%) | 15 (50.00%) | |
Hypertension, n (%) | 15 (50.00%) | 10 (33.33%) | 0.190 |
Diabetes mellitus, n (%) | 12 (40.00%) | 11 (36.67%) | 0.791 |
Ischemic heart disease, n (%) | 4 (13.33%) | 7 (23.33%) | 0.506 |
COPD, n (%) | 3 (10.00%) | 3 (10.00%) | > 0.9 |
Thyroid disease, n (%) | 2 (6.67%) | 3 (10.00%) | > 0.9 |
Fever, n (%) | 7 (23.33%) | 19 (63.33%) | 0.002 |
Chill, n (%) | 7 (23.33%) | 9 (30.00%) | 0.559 |
Dyspnea, n (%) | 25 (83.33%) | 21 (70.00%) | 0.222 |
Myalgia, n (%) | 4 (13.33%) | 18 (60.00%) | < 0.001 |
Weakness, n (%) | 2 (6.67%) | 4 (13.33%) | 0.671 |
Cough, n (%) | 26 (86.67%) | 23 (76.67%) | 0.506 |
Sputum, n (%) | 1 (3.33%) | 4 (13.33%) | 0.353 |
Headache, n (%) | 3 (10.00%) | 8 (26.67%) | 0.181 |
Vomit, n (%) | 4 (13.33%) | 2 (6.67%) | 0.671 |
Chest pain, n (%) | 2 (6.67%) | 5 (16.67%) | 0.424 |
Hemoptysis, n (%) | 0 (0%) | 3 (10.00%) | 0.237 |
Positive PCR, n (%) | 22 (73.33%) | 30 (100.00%) | > 0.9 |
Negative PCR, n (%) | 8 (26.66%) | 0 (00.00%) | |
WBC count (× 103/µl), mean (SD) | 6.60 (3.65) | 6.43 (3.69) | 0.861 |
Lymphocyte (count/µl), mean (SD) | 1082.68 (582.17) | 1042.52 (590.81) | 0.792 |
HB (g/dl), mean (SD) | 13.35 (2.29) | 12.65 (2.06) | 0.218 |
PLT (× 103/µl), mean (SD) | 194.20 (83.75) | 203.30 (74.64) | 0.658 |
AST (u/l), mean (SD) | 35.93 (15.92) | 33.93 (13.96) | 0.607 |
ALT (u/l), mean (SD) | 31.73 (8.57) | 34.43 (9.69) | 0.258 |
LDH (u/l), mean (SD) | 619.20 (212.10) | 599.67 (197.93) | 0.714 |
CRP (mg/dl), mean (SD) | 41.30 (28.86) | 58.13 (52.80) | 0.132 |
ESR (mm/hour), mean (SD) | 60.00 (30.71) | 66.03 (30.45) | 0.448 |
Body temperature upon admission(°C), mean (SD) | 37.03 (0.80) | 37.93 (0.92) | < 0.001 |
3rd day temperature (°C), mean (SD) | 36.73 (0.36) | 37.24 (0.69) | 0.001 |
Body temperature at discharge (°C), mean (SD) | 36.76 (0.47) | 36.85 (0.46) | 0.454 |
SPO2 upon admission (%), median (IQR) | 86.0 (82.0–88.0) | 87.5 (85.0–88.0) | 0.148 |
3rd day SPO2 (%), median (IQR) | 90.5 (88.0–92.0) | 88.0 (80.0–91.0) | 0.014 |
SPO2 at discharge (%), median (IQR) | 93.5 (91.0–95.0) | 92.5 (92.0–94.0) | 0.406 |
ICU length of stay (day), median (IQR) | 5.50 (5.0–10.0) | 5.0 (5.0–7.0) | 0.381 |
Hospital length of stay (day), median (IQR) | 8.50 (7.0–12.0) | 6.50(4.0–12.0) | 0.028 |
Expire, n (%) | 3 (10.00%) | 3 (10.00%) | > 0.9 |
Intubation, n (%) | 5 (16.67%) | 4 (13.33%) | > 0.9 |
Corticosteroid treatment, n (%) | 8 (26.66%) | 7 (23.33%) | 0.77 |
Severity score, mean (/10) (SD) | 3.57 (1.357) | 3.40 (1.476) | 0.651 |